Search for: "Allergan, Inc. v. Apotex Inc."
Results 21 - 40
of 44
Sort by Relevance
|
Sort by Date
7 Apr 2014, 9:59 pm
The case involved patentee Senju Pharmaceutical's (joined by Kyorin Pharmaceutical Co. and Allergan, Inc.) suit against Apotex in response to a Paragraph IV certification against Senju's patented ocular antimicrobial agent containing the drug Gatifloxacin as claimed in U.S. [read post]
1 Apr 2014, 7:17 pm
Apotex Inc., No. 2013-1027 (Fed. [read post]
13 Jan 2013, 9:06 pm
Allergan, Inc. v. [read post]
20 Apr 2012, 10:36 am
Accordingly, and consistent with its decision in Allergan, Inc. v. [read post]
18 Apr 2012, 7:28 pm
Cir. 2003) and Allergan Inc. v. [read post]
22 Feb 2012, 5:49 pm
Cir. 2003) and Allergan Inc. v. [read post]
7 Sep 2011, 4:22 am
: Pfizer v Teva (Property, intangible) [read post]
19 May 2011, 9:24 pm
Unlike Apotex, Exela appeals the district court’s finding that the product pro- posed in its ANDA infringes Allergan’s patent rights. [read post]
19 May 2011, 9:12 pm
Teleflex, Inc., 550 U.S. 398, 421 (2007). [read post]
29 Dec 2010, 2:57 am
Highlights this week included: CAFC: Broad scope of statutory subject matter: Prometheus Laboratories, Inc. v. [read post]
8 Dec 2010, 2:20 am
: Daiichi Sankyo Co Ltd v Comptroller General of Patents (The SPC Blog) Coversyl (Perindopril) – Australia: FCAFC: Servier denied patent amendment on appeal: Les Laboratoires Servier v Apotex (Patentology) Prandin (Repaglinide) – US: Paddock fails to dismiss Novo’s Prandin patent suit (Patent Docs) Spiriva (Tiotropium bromide monohydrate) – Israel: Patent status in question, in need of legislative fix (America-Israel Patent Law) Temodar… [read post]
3 Nov 2010, 1:21 am
No – discussion of patent-eligibility standards for genes (Patent Baristas) US: Appellees file reply brief in Therasense v Becton Dickinson (Patent Docs) US: Another Capitol Hill missive objects to the inclusion of patent settlement provisions in FY 2011 Appropriations Bill (FDA Law Blog) US: REMS and 180-day exclusivity forfeiture – some interesting disclosures to the SEC (FDA Law Blog) Products Botox (Botulinum) – EU: General Court upholds opposition to BOTUMAX Community… [read post]
12 Oct 2010, 8:56 pm
Highlights this week included: Aricept(Donepezil) –US: Declaratory judgment jurisdiction for subsequent Paragraph IV filers: Teva Pharmaceuticals USA, Inc. v. [read post]
23 Jun 2010, 10:28 pm
Apotex, Inc. et al. [read post]
16 Dec 2009, 3:39 am
: Ariad Pharmaceuticals, Inc. v. [read post]
1 Dec 2009, 9:45 am
Apotex Corporation and Apotex Inc. [read post]
18 Nov 2009, 4:57 am
Apotex Inc. et al. [read post]
18 Nov 2009, 4:57 am
Apotex Inc. et al. [read post]
18 Nov 2009, 4:57 am
Apotex Inc. et al. [read post]
9 Apr 2009, 7:52 am
(IP Think Tank) Brazilian public-private partnerships in the pharma industry (IP tango) EU: ECJ to rule on reference on SPC Regulation interpretation from Lithuania in Kirin Amgen, Inc. v Lietuvos Respublikos valstybinis patentų biuras (The SPC Blog) India: Delhi High Court Dasatinib order: Is patent-drug regulatory linkage a necessity? [read post]
